Literature DB >> 19801861

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Naoto Sato1, Qun Zhang, Chao-Mei Ma, Masao Hattori.   

Abstract

Five new highly oxygenated lanostane-type triterpenoids [ganoderic acid GS-1 (1), ganoderic acid GS-2 (2), ganoderic acid GS-3 (3), 20(21)-dehydrolucidenic acid N (4) and 20-hydroxylucidenic acid A (5)] were isolated from the fruiting body of Ganoderma sinense, together with known compounds including 6 triterpenoids and 3 sterols. The structures of the new triterpenoids determined by spectroscopic means including 2D NMR were 7beta-hydroxy-3,11,15-trioxo-lanosta-8,24(E)-dien-26-oic acid (1), 7beta,15alpha-dihydroxy-3,11-dioxo-lanosta-8,24(E)-dien-26-oic acid (2), 12beta-acetoxy-3beta,7beta-dihydroxy-11,15-dioxo-lanosta-8,24(E)-dien-26-oic acid (3), 3beta,7beta-dihydroxy-11,15-dioxo-25,26,27-trinorlanosta-8,20-dien-24-oic acid (4), and 7beta,20xi-dihydroxy-3,11,15-trioxo-25,26,27-trinorlanost-8-en-24-oic acid (5), respectively. Among these, ganoderic acid GS-2, 20-hydroxylucidenic acid N, 20(21)-dehydrolucidenic acid N and ganoderiol F inhibited human immunodeficiency virus-1 protease with IC(50) values of 20-40 microM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19801861     DOI: 10.1248/cpb.57.1076

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  15 in total

Review 1.  Recent advances in natural anti-HIV triterpenoids and analogs.

Authors:  Hai-Feng Wu; Susan L Morris-Natschke; Xu-Dong Xu; Mei-Hua Yang; Yung-Yi Cheng; Shi-Shan Yu; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2020-07-14       Impact factor: 12.944

Review 2.  Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Authors:  S F Yanuck; J Pizzorno; H Messier; K N Fitzgerald
Journal:  Integr Med (Encinitas)       Date:  2020

3.  Ganoderiol F purified from Ganoderma leucocontextum retards cell cycle progression by inhibiting CDK4/CDK6.

Authors:  Xiangmin Li; Yizhen Xie; Juanjuan Peng; Huiping Hu; Qingping Wu; Burton B Yang
Journal:  Cell Cycle       Date:  2019-09-22       Impact factor: 4.534

Review 4.  Mushrooms: an emerging resource for therapeutic terpenoids.

Authors:  Adhiraj Dasgupta; Krishnendu Acharya
Journal:  3 Biotech       Date:  2019-09-24       Impact factor: 2.406

5.  Comparison of sterols and fatty acids in two species of Ganoderma.

Authors:  Guang-Ping Lv; Jing Zhao; Jin-Ao Duan; Yu-Ping Tang; Shao-Ping Li
Journal:  Chem Cent J       Date:  2012-01-31       Impact factor: 4.215

Review 6.  Traditional uses, chemical components and pharmacological activities of the genus Ganoderma P. Karst.: a review.

Authors:  Li Wang; Jie-Qing Li; Ji Zhang; Zhi-Min Li; Hong-Gao Liu; Yuan-Zhong Wang
Journal:  RSC Adv       Date:  2020-11-18       Impact factor: 4.036

7.  Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships.

Authors:  Shaodan Chen; Xiangmin Li; Tianqiao Yong; Zhanggen Wang; Jiyan Su; Chunwei Jiao; Yizhen Xie; Burton B Yang
Journal:  Oncotarget       Date:  2017-02-07

Review 8.  Potential of small-molecule fungal metabolites in antiviral chemotherapy.

Authors:  Biswajit G Roy
Journal:  Antivir Chem Chemother       Date:  2017-07-23

Review 9.  Current and future perspective on antimicrobial and anti-parasitic activities of Ganoderma sp.: an update.

Authors:  Buddha Bahadur Basnet; Li Liu; Li Bao; Hongwei Liu
Journal:  Mycology       Date:  2017-05-24

10.  Structure elucidation and immunomodulatory activity of a beta glucan from the fruiting bodies of Ganoderma sinense.

Authors:  Xiao-Qiang Han; Gar-Lee Yue; Rui-Qi Yue; Cai-Xia Dong; Chung-Lap Chan; Chun-Hay Ko; Wing-Shing Cheung; Ke-Wang Luo; Hui Dai; Chun-Kwok Wong; Ping-Chung Leung; Quan-Bin Han
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.